Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription 27.06.2022 1 BMJ 1 Gastroenterol Hepatol 4 Hepatology 6 J Hepatol 9 J Viral Hepat 1 MMWR Morb Mortal Wkly Rep 3 PLoS One 2 PLoS Pathog

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. SALMON R, Palmer S
   Recent hepatitis outbreak in children may have a foodborne toxin as its cause.
   BMJ. 2022;377:o1518.
   PubMed        
   
   

   
   Gastroenterol Hepatol

2. GUTIERREZ-ROJAS L, de la Gandara Martin JJ, Garcia Buey L, Uriz Otano JI, et al
   Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: results of a literature review.
   Gastroenterol Hepatol. 2022 Jun 16. pii: S0210-5705(22)00164.
   PubMed         Abstract available
   
   

   
   Hepatology

3. BARNES E, Cooke GS, Lauer G, Chung RT, et al
   Implementation of a Controlled Human Infection Model for Evaluation of HCV Vaccine Candidates.
   Hepatology. 2022 Jun 23. doi: 10.1002/hep.32632.
   PubMed         Abstract available
   
   
4. ZHAO K, Guo F, Wang J, Zhong Y, et al
   Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells.
   Hepatology. 2022 Jun 19. doi: 10.1002/hep.32622.
   PubMed         Abstract available
   
   
5. FUNG S, Choi HSJ, Gehring A, Janssen HLA, et al
   Getting to HBV cure: The promising paths forward.
   Hepatology. 2022;76:233-250.
   PubMed         Abstract available
   
   
6. WU CR, Kim HJ, Sun CP, Chung CY, et al
   Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants.
   Hepatology. 2022;76:207-219.
   PubMed         Abstract available
   
   

   
   J Hepatol

7. HOOGEVEEN RC, Dijkstra S, Bartsch LM, Drescher H, et al
   Hepatitis B virus-specific CD4 T-cell responses differentiate functional cure from chronic surface antigen(+) infection.
   J Hepatol. 2022 Jun 15. pii: S0168-8278(22)00366.
   PubMed         Abstract available
   
   
8. MEDAS R, Liberal R, Cardoso H, Macedo G, et al
   2022 International Autoimmune Hepatitis Group non-response criteria in autoimmune hepatitis: a too early endpoint?
   J Hepatol. 2022 Jun 15. pii: S0168-8278(22)00367.
   PubMed        
   
   
9. YUEN MF, Heo J, Kumada H, Suzuki F, et al
   Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.
   J Hepatol. 2022 Jun 14. pii: S0168-8278(22)00351.
   PubMed         Abstract available
   
   
10. AGARWAL K, Lok J, Carey I, Shivkar Y, et al
    A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV 'cure'.
    J Hepatol. 2022;77:245-248.
    PubMed         Abstract available
    
    
11. LAI MW, Chang YL, Cheng PJ, Chueh HY, et al
    Absence of chronicity in infants born to immunized mothers with occult HBV infection in Taiwan.
    J Hepatol. 2022;77:63-70.
    PubMed         Abstract available
    
    
12. HUANG D, Wu D, Wang P, Wang Y, et al
    End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB.
    J Hepatol. 2022;77:42-54.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

13. CHU JH, Huang Y, Xie DY, Deng H, et al
    Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.
    J Viral Hepat. 2022 Jun 19. doi: 10.1111/jvh.13722.
    PubMed         Abstract available
    
    
14. LIM J, Lee JB, An J, Song GW, et al
    Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000-Korean outcome study.
    J Viral Hepat. 2022 Jun 19. doi: 10.1111/jvh.13721.
    PubMed         Abstract available
    
    
15. YAO N, Wang J, Wu Y, Zhu Y, et al
    Frequent alanine aminotransferase flares and promising antiviral therapy efficacy during the preschool age: an opportunity to achieve HBsAg loss in children with mother-to-child transmitted hepatitis B.
    J Viral Hepat. 2022 Jun 20. doi: 10.1111/jvh.13720.
    PubMed         Abstract available
    
    
16. TRAEGER MW, van Santen DK, Sacks-Davis R, Asselin J, et al
    Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs.
    J Viral Hepat. 2022 Jun 20. doi: 10.1111/jvh.13723.
    PubMed         Abstract available
    
    
17. XU JH, Fan YN, Yu YY, Si CW, et al
    240-week Entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C.
    J Viral Hepat. 2022 Jun 23. doi: 10.1111/jvh.13724.
    PubMed         Abstract available
    
    
18. TAYE BW, Valery PC, Clark PJ
    Targeted antiviral treatment of hepatitis B virus in culturally and linguistically diverse populations to achieve elimination targets in Australia.
    J Viral Hepat. 2022 Jun 24. doi: 10.1111/jvh.13727.
    PubMed         Abstract available
    
    
19. SHATA MTM, Hetta HF, Sharma Y, Sherman KE, et al
    Viral Hepatitis in Pregnancy.
    J Viral Hepat. 2022 Jun 24. doi: 10.1111/jvh.13725.
    PubMed         Abstract available
    
    
20. FACTOR SH, Fierer DS
    Can Treatment, Without Prevention, Eliminate Hepatitis C Among Men Who Have Sex With Men?
    J Viral Hepat. 2022 Jun 24. doi: 10.1111/jvh.13726.
    PubMed        
    
    
21. RIOS-HINCAPIE CY, Murad-Rivera R, Tohme RA, Ropero AM, et al
    Progress towards the elimination of hepatitis B in children in Colombia: a novel two-phase study approach.
    J Viral Hepat. 2022 Jun 16. doi: 10.1111/jvh.13719.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

22. KAMBHAMPATI AK, Burke RM, Dietz S, Sheppard M, et al
    Trends in Acute Hepatitis of Unspecified Etiology and Adenovirus Stool Testing Results in Children - United States, 2017-2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:797-802.
    PubMed         Abstract available
    
    

    
    PLoS One

23. SIEDLECKA M, Kublicka A, Wieliczko A, Matczuk AK, et al
    Molecular detection of avian hepatitis E virus (Orthohepevirus B) in chickens, ducks, geese, and western capercaillies in Poland.
    PLoS One. 2022;17:e0269854.
    PubMed         Abstract available
    
    
24. ISUNJU JB, Wafula ST, Ndejjo R, Nuwematsiko R, et al
    Awareness of hepatitis B post-exposure prophylaxis among healthcare providers in Wakiso district, Central Uganda.
    PLoS One. 2022;17:e0270181.
    PubMed         Abstract available
    
    
25. RAU M, Buggisch P, Mauss S, Boeker KHW, et al
    Prognostic impact of steatosis in the clinical course of chronic HCV infection-Results from the German Hepatitis C-Registry.
    PLoS One. 2022;17:e0264741.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

26. ISKEN O, Walther T, Wong-Dilworth L, Rehders D, et al
    Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity.
    PLoS Pathog. 2022;18:e1010644.
    PubMed         Abstract available
    
    
27. HONG X, Kawasawa YI, Menne S, Hu J, et al
    Host cell-dependent late entry step as determinant of Hepatitis B virus infection.
    PLoS Pathog. 2022;18:e1010633.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: